SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)

NCT00732810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: SCH 727965
DRUG: Capecitabine
DRUG: Erlotinib

Sponsor

Merck Sharp & Dohme LLC